Oil Storage Market 2017-2021: Key Segments & Opportunity Analysis with Capacity and Capital Expenditure Forecasts

Latest market research reports on “Global Oil Storage Industry Outlook to 2021-Capacity and Capital Expenditure Forecasts” available with OrbisResearch.com.

DALLAS, TEXAS, UNITED STATES, March 31, 2017 /EINPresswire.com/ — "Global Oil Storage Industry Outlook to 2021 – Capacity and Capital Expenditure Forecasts with Details of All Operating and Planned Terminals" is a comprehensive report providing information on storage terminals that store crude oil, petroleum products and chemicals worldwide. Typical information on terminals includes terminal name, operator name, storage capacity and commodity stored for all active and planned terminals. The report also provides capital expenditure outlook by key countries, year on year, from 2017 to 2021. The report also provides key country comparisons within a region and regional comparisons, based on contribution to total storage capacity (regional / global). Planned (new build) terminals capacity addition and existing capacity expansions, as announced by the companies have also been included. Further the report also offers recent developments and latest awarded contracts at regional level.

Request a sample of Oil Storage Market 2021 @ http://www.orbisresearch.com/contacts/request-sample/244307 .

Scope
– Updated information relating to all active and planned oil storage terminals
– Provides historical data from 2011 to 2016, forecast to 2021
– Capacity information of all oil storage terminals
– Provides operator information for all active and planned oil storage terminals
– Latest developments and contracts related to oil storage terminals

Reasons to buy
– Obtain the most up to date information available on active and planned oil storage terminals globally
– Identify growth segments and opportunities in the industry
– Facilitate decision making on the basis of strong historic and forecast capacity data
– Assess your competitor’s oil storage terminals

Place a direct purchase order on the report @ http://www.orbisresearch.com/contact/purchase/244307 .

Major Points from Table of Contents:
1 Table of Contents
2. Introduction 29
3. Global Oil Storage Industry 30
4. Africa Oil Storage Industry 50
5. Asia Oil Storage Industry 101
6. Caribbean Oil Storage Industry 188
7. Central America Oil Storage Industry 216
8. Europe Oil Storage Industry 239
9. Former Soviet Union Oil Storage Industry 324
10. Middle East Oil Storage Industry 361
11. North America Oil Storage Industry 421
12. Oceania Oil Storage Industry 530
13. South America Oil Storage Industry 558
14. Appendix 597

If you have inquiries before buying the report, contact us @ http://www.orbisresearch.com/contacts/enquiry-before-buying/244307 .

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Hector Costello
Orbis Research
+1 (214) 884-6817
email us here


Source: EIN Presswire

“Trial of the century” to be continued in June

Michael-Schmidt-Walkerton-raw-milk-trial

Michael Schmidt and Four Others Cited with Obstructing a Police Officer.

glencolton-farms-dairy-michael-schmidt

Glencolton Farms

michael-schmidt-raw-dairy

Farmer Michael Schmidt leading his dairy herd.

Raw milk raid subject to scrutiny in court proceedings

This is overkill. We are peaceful farm owners. The arresting officers put us in the category of domestic terrorists just because we want to continue drinking fresh milk from our cows.”

— Beverly Viljakainen, witness for the defense

WALKERTON, ONTARIO, CANADA, March 30, 2017 /EINPresswire.com/ — A 10-day trial of four farmers came to a close last Friday, March 24, 2017. It became clear to the judge early in the trial that the 5-days allocated were not enough. After 10 days, the judge adjourned the trial until June due to lack of courtroom space.

An added challenge to the court proceedings was the investigating officer’s false claim that the farmers were members of the “Freemen of the Land” extremist group which led to the presence of a special police force during trial and mandatory heightened security.

The classification was sent to a national database and to border agencies affecting the accused in many aspects of their private lives and putting tremendous burden on them. During the trial, the officer who got the arrest warrant, under oath retracted the assertion that the arrestees were part of the “Freeman of the Land” extremist group.

Walkerton court employees jokingly call the criminal charges against the farmers, and the subsequent court proceedings, the “trial of the century” These four men, along with a fifth whose charges were dropped, were charged with obstructing a police officer during a well-publicized raid on Glencolton Farms on October 2nd 2015.

The four men on trial are Michael Schmidt an outspoken activist on food rights who lives on the farm that was raided; Robert Pinnell, whose charges were recently dismissed due to lack of evidence; John Schnurr, business consultant; and George Bothwell who was still at-large prior to the trial but was arrested when he appeared in court.

Glencolton Farms co op owners testified about the dramatic stand-off at their farm where they source their food. The farm has been the center of the Canadian raw milk battle for over 23 years. 150 families who are members in the Our Farm-Our Foods cooperative, own Glencolton Farms dairy cooperatively.

“This is overkill,” says Beverly Viljakainen one of the witnesses called by the defense at the trial. “We are peaceful farm owners. The arresting officers put us in the category of domestic terrorists just because we want to continue drinking fresh milk from our cows. When will this absurdity stop?”

The date in June for the continuation of the trial has not been determined. None of the remaining three defendants are in custody. All three defend themselves without a lawyer

For more info on the raid, see this Facebook video.

Our Farms, Our Foods Coop is a 200 member cooperative formed for the purpose of boarding personal cows with a responsible dairyman. The group is just one of the many interested stakeholders in changing Canadian policy on raw milk. For additional information on raw milk www.realmilk.com For more on this case see The Bovine.

Photo Caption: Five men are from left to right: Michael Schmidt, John Schnurr, George Bothwell, Enos Martin, Robert Pinnell.

Liz Reitzig
HartkePR.com
301-807-5063
email us here


Source: EIN Presswire

A Chance to Win A 2017 BMW Proceeds benefit New Hope for Kids



We want you…to Win a BMW

Tickets still available to support Central Florida's only grief center for children and families

ORLANDO, FLORIDA, UNITED STATES, March 30, 2017 /EINPresswire.com/ — Now's your chance to win a BMW! New Hope for Kids is once again offering a chance to win a new 2017 BMW 320i during our 27th Annual Drawing of Chance. The odds are extremely good for someone to win. There are only 2000 tickets! All proceeds go to New Hope for Kids.Find out more about New Hope for Kids unique and profound mission at www.newhopeforkids.org/bmw.

§ Tickets are $100 each, or sets of 2 for $150. (Your donation is tax-deductible as allowed by law.)

§ Only 2000 tickets available!

§ BMW drawing of chance takes place on April 21, 2017 at our annual Art of the Vine (http://newhopeforkids.org/aov/) event.
(admission to event sold separately, need not be present to win)

New Hope for Kids provides specialized grief support for those suffering from grief and provides hope for the future.
##

Since 1996, New Hope for Kids has been helping Central Florida children in need. Our purpose is to bring hope, healing and happiness to children and families suffering from grief, loss or life-threatening illnesses.New Hope for Kids achieves this through two programs:

The Center for Grieving Children (http://newhopeforkids.org/center-grieving-children/) helps children and families cope with the feelings of grief and loss after the death of a loved one.

Wishes for Kids (http://newhopeforkids.org/wishes-kids/) grants wishes to children up to the age 19, diagnosed with a life-threatening illness.

Funding comes primarily through charitable donations by individuals, corporations, foundations and community service organizations in Central Florida. No funding is received from government agencies. New Hope for Kids is a registered 501(c)(3) organization.Find out more about New Hope for Kids unique and profound mission at www.newhopeforkids.org/bmw.

gloria capozzi
New Hope for kids
407-331-3059
email us here


Source: EIN Presswire

Intermountain Healthcare Awarded National 2017 Hearst Health Prize

Intermountain Healthcare Receives Hearst Award

Awarded for Mental Health Integration program

SALT LAKE CITY, UTAH, USA, March 30, 2017 /EINPresswire.com/ — Hearst Health, a division of Hearst, and the Jefferson College of Population Health of Thomas Jefferson University, have announced that Utah-based Intermountain Healthcare is the winner of the 2017 Hearst Health Prize. Intermountain was awarded the prize for its Mental Health Integration program, which embeds mental health screening and treatment within primary care and select specialty practices. The Hearst Health Prize is an annual $100,000 award given in recognition of an organization’s or individual’s outstanding achievement in managing or improving health in the U.S.

Intermountain created a Mental Health Integration program for patients that made mental health evaluation and service part of the routine care for patients seeking care at Intermountain, with an emphasis on primary care. It utilizes a team-based approach, built upon systematic, evidence-based medicine that is collaborative and measurable, to help patients and their families manage the complexity of both mental and physical health.

More than 100,000 patients were tracked over a 10-year period to observe their outcomes and interactions. Findings of the study included:

• At Intermountain Healthcare, 46 percent of patients in team-based practices were screened for active depression, more than ten times greater than that of traditional physician practices nationally, according to some studies.

• More patients adhered to diabetes care protocols and had documented self-care plans.

• For individuals receiving care through the mental health integration program, emergency room visits dropped 23 percent, hospital admissions declined 10 percent, and primary care doctor visits declined 7 percent.

• With these improvements, the overall cost of care for patients with active depression dropped by more than three percent. Based on Intermountain Healthcare’s experience, they project at least $4 billion in annual U.S. healthcare savings if their mental health integration model was used nationally.

“The caregivers at Intermountain are grateful to receive this recognition and award,” said Marc Harrison, MD, Intermountain president and CEO. “It honors our commitment to our patients, their families, and the communities we serve. It honors our caregivers with whom our patients trust to provide the highest quality, effective, and affordable care.”

Intermountain Healthcare is a not-for-profit system of 22 hospitals, 180 clinics, a Medical Group with about 1,500 employed physicians and advanced practitioners, a health plans group called SelectHealth, and other medical services. Intermountain is widely recognized as a leader in transforming healthcare through high quality and sustainable costs. For more information about Intermountain, visit www.intermountainhealthcare.org.

Daron Cowley
Intermountain Healthcare
801-442-2834
email us here


Source: EIN Presswire

Follow the Sweet Scents to the Santa Maria Valley’s 30th Annual Strawberry Festival

The 30th Annual Santa Maria Valley Strawberry Festival kicks of the valley’s strawberry season on April 28-30, 2017 at the Santa Maria Fairpark.

RENO, NEVADA, UNITED STATES, March 30, 2017 /EINPresswire.com/ — (Santa Maria, Calif.) – The 30th Annual Santa Maria Valley Strawberry Festival kicks of the valley’s strawberry season on April 28-30, 2017 at the Santa Maria Fairpark. The festival supports local agriculture and encourages the healthy indulgence of strawberries, all in a fun-filled, three-day weekend community event.

The festival will showcase local talent, and offer a wide variety of activities. With paid admission, visitors will enjoy a multitude of free attractions ranging from cooking demonstrations to educational and wildlife exhibits to strawberry tasting and dessert eating contests.

The Strawberry Festival also features pony rides, a traditional carnival, including a kiddie area, commercial displays and a free petting zoo.

Be awed by local farmers and growers who will offer farm fresh, sweet and beautiful berries displayed for sale. Visitors will see some of the many variations of the strawberry, as well as other traditional fun carnival foods, all in a wholesome and entertaining venue.

There will be a Strawberry Art Contest open to children in grades 1 – 8 attending school in Northern Santa Barbara County All entries must be submitted to the Santa Maria Fairpark at 937 S. Thornburg St., Santa Maria, Calif., 93458 no later than 5 p.m. on Friday, April 15th. Entries will be judged on the following three criteria: Originality, artistic composition and relevant content.

Festival gates open at 11 a.m. and close at 10 p.m. The carnival may stay open until midnight. Tickets are $10 general admission, $7 for youth 6-11 years old, $7 for seniors 62 years old and above, and children under 5 years old are free. Carnival unlimited daily ride wristbands are $30 each.

In addition, theme days are as follows:

SENIOR DAY – Friday, April 28
• Seniors 62+ receive free admission
• Carnival Wristbands – Buy One, Get One Free before 3:00 p.m.

KID'S DAY – Saturday, April 29
• Kids 6 -11 years old receive $1 admission, all day
• Kids 5 yrs. old and younger receive free admission, all day (everyday)

FIESTA DAY – Sunday, April 30
• Special concert event held in the Minetti Arena (separately ticketed event)
• Hispanic themed entertainment throughout grounds

For more information on the Strawberry Festival, visit santamariafairpark.com.

The Santa Maria Valley enjoys a year-round berry growing season and a cool, coastal climate. The Santa Maria Valley happens to be home to some of the ripest, juiciest, largest strawberries in the country. Strawberry fields are replanted annually, producing higher quality fruit with larger yields year after delicious year.

With more than 10 strawberry varieties grown in the valley, Santa Maria Valley strawberries are distributed worldwide allowing taste buds from all over the globe a bite of homegrown goodness. For locals and visitors to the valley alike, the best places to find Santa Maria-grown strawberries are right here in the beautiful Valley, at roadside stops, at the Strawberry Festival or at weekly Farmers Markets.

The Santa Maria Valley is also an ideal homebase for Central California Coast visitors. Tour the welcoming vineyards and swirl your glass ‘til you spill. Indulge in the 150-year old Santa Maria-style barbecue tradition that is the area’s best hidden gem. Watch the sunset over the dunes, and let your hair fly around in the ocean breeze. The Travel Channel recently named the Santa Maria Valley The New Top 10 Cities for Wine Snobs.’

About Santa Maria Valley:
Whether it is the perfect pairing with a renowned Pinot Noir, a bite of tasty simplicity with Santa Maria-style barbecue or gazing at the natural wonders of the Guadalupe-Nipomo Dunes National Wildlife Refuge, get together in Santa Maria Valley. You and your loved ones will discover the culture, tradition and authenticity of the Central California coast, with enough left in your pocket to do it all again tomorrow. For details on Santa Maria Valley lodging, wine tasting, travel deals, attractions, upcoming events and e-newsletter alerts, visit santamariavalley.com or call (800) 331-3779.

Chrisie Yabu
KPS3
775-686-7437
email us here


Source: EIN Presswire

Manfrotto Distribution US adds 360Rize to its Line of Power Brands

(Animated) 360 Video resolution matters when it comes to quality of HMD viewing. Today HMD’s support 4K however be prepared for the future HMD’s and other display formats.

(Still) 360 Video resolution matters when it comes to quality of HMD viewing. Today HMD’s support 4K however be prepared for the future HMD’s and other display formats.

Over 21 different 360 Video Rigs for GoPro and 14 different rigs using Yi Technology cameras.

360Rize, a company specializing in virtual reality 360 video technology, announced its product line is now being distributed by Manfrotto Distribution Inc.

Manfrotto a Vitec Group Company (NYSE:VTC)

When it comes to camera and production equipment distribution, Manfrotto Distribution US is one of the most respected names in the industry and we're thrilled to be working with them.”

— Michael Kintner, 360RIZE CEO

UPPER SADDLE RIVER, N.J., UNITED STATES, March 30, 2017 /EINPresswire.com/ — Upper Saddle River, N.J. (March 30, 2017) – 360Rize, a company specializing in virtual reality 360 video technology, announced its product line is now being distributed by Manfrotto Distribution US, which will now add the 360Rize line of patented 360 Plug-N-Play™ to its inventory of professional video and photo products, serving as a reselling resource for dealers.

360Rize’s hardware products serve as 360 video arrays for multiple cameras and allow content creators to film 360-degree videos at resolutions as high as 16,000 x 8,000 pixels. This includes 2D and 3D stereoscopic VR camera mounts and the 360-degree camera systems. Content filmed with these products can be viewed in large projection domes, Mac's, PC's, multiple web and 360 media players or with Oculus Rift, Samsung Gear VR, Google Cardboard and other virtual reality HMDs (head-mounted displays).

"This is a very exciting step for 360Rize. When it comes to camera and production equipment distribution, Manfrotto Distribution US is one of the most respected names in the industry and we're thrilled to be working with them to help make 360 video technology widely available," said 360Rize CEO and founder Michael Kintner.

"VR and 360 shooting is one of the most exciting new channels in imaging. We are thrilled to be representing 360Rize as their US Distributor. Their products are of the highest quality and help define the category. So, in that sense, they are very much like the Manfrotto brand. That is why they are the perfect partner for us," said Adam Mirabella, President of Manfrotto Distribution US.

This news follows the announcement that 360Rize was awarded a patent and multiple provisional patents for its virtual reality 360 video technology patented 360 Plug-n-Play™ product lines. These systems re-purpose small action camera’s like GoPro™, Yi™ Technology and micro-cinematic cameras like Blackmagic Designs and ZCam’s into the unique patented 360 Plug-n-Play™ camera arrays for creating high resolution spherical 360 video. The patent covers the multi-camera holding assemblies which its original 360Heros company brought to the market back in 2012.

About 360Rize/360Heros Inc:
360Rize a 360Heros Inc., company specializing in virtual reality 360 video technology, creates 360 spherical video camera systems that capture 360 video content as high as 12K resolution VR content. 360Rize also develops 360 video workflow solutions such as 360CamMan™, the world’s first VR media management software and many other 360 video work flow solutions. Through years of research and innovation, 360Rize is empowering content creators to push the limits of this emerging technology and its unique modular 360 Plug-n-Play product line it allows producers to use the action and cinematic cameras in multi-camera arrays or unplug them and use them as they were intended allowing producers to efficiently camera manage their video equipment for multiple purposes.

For additional information about 360Rize formerly 360Heros, visit www.360rize.com. Follow 360Rize on Facebook at www.facebook.com/360Rize, on Twitter www.twitter.com/@360_Rize or www.instagram.com/360rize.

About Manfrotto (Vitec Group) – www.manfrotto.us
Manfrotto is the world leader in the design, production and distribution of professional products for photography, video and entertainment. The company was founded in 1972 based on Lino Manfrotto’s experience, and its mission has always been to support and simplify the work of reporters, photographers and producers. The Imagine More project adds to this historical mission the idea of fueling the enthusiasm of weekend photographers and supporting the surge of new amateurs. Part of the UK-based Vitec Group since 1989, Manfrotto has now become a worldwide presence. In its nine key markets – Italy, France, Germany, the United Kingdom, China, Japan, Hong Kong, the United States and from 2016 in the Netherlands – it is represented by its own direct distribution system, Manfrotto Distribution, whereas in 80 other countries sales are handled by independent distributors. Through the Imaging Division of Vitec Group, Manfrotto Distribution owns the following leading international brands: Manfrotto, Gitzo, Lastolite by Manfrotto, Avenger and is the U.S. distributor of Bowens, Gossen, Metz and National Geographic.

For additional information about Manfrotto, visit manfrotto.us. Follow Manfrotto on Facebook at www.facebook.com/ManfrottoSchoolOfXcellence, on Twitter www.twitter.com/@manfrotto_us or wwww.instagram.com/manfrottoimaginemore.

Diane DiVincenzo
Manfrotto
(201) 818-9500 ext 8262
email us here


Source: EIN Presswire

VARStreet to Attend Channel Partners Conference & Expo Exhibition 2017

VARStreet will be exhibiting (booth #331) at the 2017 Channel Partners Conference and Expo in Las Vegas, promoting its cloud-based business management platform.

BURLINGTON, MA, USA, March 30, 2017 /EINPresswire.com/ — VARStreet will be participating at Channel Partners & Expo 2017, the premier networking event for VARS, MSPs, integrators and service provider from across the IT channel. It is a 4-day event and will be held from 10th April to 13th April at the Mandalay Bay, Las Vegas, United States of America.

Hosted annually by Channel Partners, the conference attracts thousands of agents, VARs, MSPs, integrators and service providers who converge to share ideas and drive discussion on the topics shaping our industry.

During the Channel Partners Conference & Expo event 2017, VARStreet will engage with a large number of IT professionals and showcase its business management platform that includes Catalog Management, Sales Quoting, Procurement, CRM & E-Commerce. To secure an appointment with VARStreet at Channel Partners, please email sales@varstreet.com or call 781-262-0609. Event attendees are encouraged to visit VARStreet at booth number 331 during the event.

Shiv Agarwal, Vice President – Sales, VARStreet says “At Channel Partners Expo, the kind of attendees that visit meet our requirements that we are looking for in a prospect. We are happy to be participating in the event and we are looking forward to meeting new prospects as well as existing customers.”

About Channel Partners
Channel Partners is a leader in providing news and analysis to alternate distribution channels serving the communications industry. This IT channel event features concurrent education, networking events, keynotes by industry leaders and observers, and more than 250+ exhibitors.

About VARStreet
VARStreet is a cloud based all-in-one business management software for all IT & Office Supplies VARS MSP’s System Integrators & Solution Providers in USA and Canada. Founded in 1999, VARStreet has worked with 4000+ VARS and 15,000+ VAR users, collective wisdom of which has helped us create the industry leading VAR Business Management application. VARStreet comprehensive Business Management suite includes – integration with 35+ distributors for daily catalog and pricing update, a very robust Quoting Module with a Mobile Quoting App for anytime anywhere quoting, CPQ (Configure, Price, Quote solution) for large enterprise VARS, CRM (Customer Relationship Management), Sales Order Management, Purchasing / Procurement Management and a sophisticated eCommerce Store. VARStreet also integrates with all leading CRM, Accounting and ERP applications. VARStreet also comes with an in-house team of 50+ engineers to handle all customizations and professional service requirements.

Press Contacts

Roshan Tayade
rtayade@varstreet.com

Shiv Agarwal
VARStreet Inc
7812620610
email us here


Source: EIN Presswire

Bloor Rates MENTIS an Innovator

MENTIS stands out in newly released 2017 Market Update for Test Data Management

NEW YORK, NEW YORK, USA, March 30, 2017 /EINPresswire.com/ — MENTIS Software (www.MENTISoftware.com), the pioneer in data masking and enterprise data security products, today announced its inclusion and strong performance in Bloor’s most recent Market Update for Test Data Management publication. The research group’s 2017 survey focused on different approaches to test data management, trends in the market, and top vendors for static data masking.

“Test Data Management can be a key area of vulnerability,” said Rajesh Parthasarathy, MENTIS’ founder and CEO. “Our entire focus from day one at MENTIS has been about protecting data on the front lines –where data is stored, accessed, used. Knowing how processes often create exposure risk, such as in test data, means MENTIS’ discovery and masking solutions can take on the job of protecting the data throughout its lifecycle — and do it in a way that means security won’t get in the way of doing business. So business can get on with the task at hand, confident that the data is secure.”

For Test Data Management environments, MENTIS’ iDiscover and iScramble (static data masking), along with blended data masking and iSubset, are the essentials to reduce risk.

Bloor called MENTIS discovery capabilities excellent, and market leading. “MENTIS goes further, in our opinion, than any other supplier in its facilities for discovering sensitive data,” said Philip Howard, Bloor Research Director, Information Management. “We are particularly impressed with the Discovery capabilities offered by MENTIS. This, combined with robust masking capabilities and relative ease of use, plus the add-on capabilities of iRetire, makes MENTIS the leading technical provider of solutions that purely offer subsetting.”

Comments of note from the report:
• The company offers a number of unique or near unique features such as location-based, conditional masking and time-slice-based subsetting.
• iRetire will be especially beneficial in regulated environments such as the EU’s GDPR (general data protection regulation).
• The company’s offering (which also includes iMonitor and iProtect) is much broader in scope than most of its competitors. Only one other vendor could offer something comparable but that would be in diverse products that are not well integrated.

“MENTIS has been the visionary and early pioneer in sensitive data security, with a “tackle the risk” approach that keeps us ahead of the curve. MENTIS has led the way for other companies entering the space,” said Suresh Sundaram, MENTIS Executive Director. “The perspective from the Bloor Market Update speaks directly to this approach and provides independent affirmation that MENTIS’ discovery, static data masking, dynamic data masking, and other offerings continue to break new ground.”

To learn more key findings and recommendations contact Bloor. To learn more about us, contact MENTIS.

About Bloor
Bloor Research is one of Europe’s leading IT research, analysis and consultancy organizations. Founded in 1989, Bloor Research is an independent research and analyst house and has spent 25 years distributing research and analysis to IT user and vendor organizations throughout the world via online subscriptions, tailored research services, events and consultancy projects.

Bloor helps companies and organizations navigate complex business situations, converting challenges into new opportunities for real growth, profitability, and impact and enables organizations to choose the optimal technology solutions for their for their success.

About MENTIS
MENTIS brings the most advanced application and data security platform to the market. The cornerstone is iDiscover, which provides certainty about where data is and identifies the programs that put it there. Masking solutions include iMask and iScramble which, combined with iMonitor, wrap security around the data where it resides. Blended Data Masking can address use-specific cases. And iRetire and iSubset can be used to further reduce exposure. The result is a fully integrated platform that pro-actively tackles risk to data at its exposure points along its lifecycle in the customer’s system.

MENTIS’ products are designed to share sensitive data intelligence and a common database architecture. Benefits include clear SOD capabilities and ease-of-implementation through low-overhead/high-performance architecture. The platform enables customers to secure at-risk data across its lifecycle, in on-premise, hosted, and cloud environments, and on Production, Pre-Production, Non-Production, mainframe and relational databases; and file servers.

MENTIS 8, the most recent release announced last December, is the company’s most significant version release to date, and extends its platform to enable security in critical data stores such as unstructured data, data in the cloud, and data in mainframe databases. It also adds a new format-preserving encryption option to its existing masking and tokenization methods and features a new, metro-style UI with fresh and easily digestible infographic elements.

The enterprise-ready platform uses shared sensitive data intelligence and a common database architecture across products; brings clear segregation of duties capabilities; and adds ease of implementation on a low-overhead/high-performance architecture.

Founded in 2004, and guided by a visionary with deep grounding in both business and technology, MENTIS immediately began to innovate and has since been named a “Cool Vendor,” “Visionary” and a “Challenger” in Gartner’s Magic Quadrant for Data Masking and an “Innovator” in the 2017 Bloor Market Update for Test Data Management and the 2015 Bloor Data Masking Market Update.

Harriet Schneider
MENTIS Software
800-267-0858
email us here


Source: EIN Presswire

Global HIV Vaccines Market Research Report 2017 Analysis and Forecast to 2027



HIV Vaccines Market

WiseGuyReports.com adds “HIV Vaccines Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2027”reports to its database

PUNE, INDIA, March 30, 2017 /EINPresswire.com/ — HIV Vaccines Market:

Executive Summary

Vaccines empower the human immune system to protect against infection or disease. Vaccines against HIV are being developed, and tested in phases of clinical trials. At present, none of the HIV vaccines are commercially available.

More than 30 HIV candidate vaccines have been tried in roughly 60 Phase I/II trials, involving more than 10,000 healthy volunteers. A large portion of these trials have been conducted in the United States & Europe, and a few in developing countries such as Brazil, Peru, China, and Thailand. The outcomes have affirmed the safety of the vaccines, and have given important scientific information to create fresher eras of candidate vaccines with better capacity to induce anti-HIV specific immune responses.

Request Sample Report @ https://www.wiseguyreports.com/sample-request/860844-global-hiv-vaccines-market-development-and-forecast-to-2027

This research report provides in-depth information about the various market segments. It shall also provide qualitative information about the current and upcoming trends in HIV vaccines market, globally.
The market is majorly divided on the basis of phases of clinical trials and regions. Globally, North America commands the largest market share of around 44% of the global market. This large share is majorly attributed to high adoption of various HIV vaccine trials coupled with the technological advancement in the region. North America is one of the important partners for HIV prevention & research for the development of HIV vaccine, as well as for reduction and prevention of HIV. It has been revealed that more than $600 million a year is invested into HIV vaccine R&D, with the major share coming from the US National Institutes of Health. United States was the first country to carry out the first Phase I trial of an HIV candidate vaccine in 1987. Since then, more than 30 distinctive candidate vaccines have been developed by many organizations, utilizing various technologies mostly in the United States.

Growing number of market players, increasing awareness about HIV prevention among various nations, rising prevalence of HIV, and rising funds for HIV vaccines research, are some of the key factors propelling the growth of HIV vaccines market. However, hindrance during HIV vaccine approval process is limiting the market growth to a great extent.

Some of the key players of the market are GlaxoSmithKline plc (U.K.), SANOFI (France), Argos Therapeutics, Inc. (U.S.), Bionor Pharma ASA (Norway), Janssen Global Services, LLC (U.S.), GENECURE LLC (U.S.), GeoVax (U.S.), GENVEC, INC. (U.S.), PaxVax Corporation (U.S.), and Inovio Pharmaceuticals, Inc. (U.S.).

STUDY OBJECTIVES OF HIV VACCINES MARKET DEVELOPMENT AND FORECAST TO 2027
• To provide insights about factors, influencing and affecting the market growth
• To provide present and forecast revenue of the market segments and sub-segments with respect to regional markets and their countries
• To provide present as well as forecast revenue of the market segments based on products, and sub-segments for global HIV vaccines market
• To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic and ethical factors that influences the global HIV vaccines market

Target Audience
• Pharmaceutical companies
• Research Laboratories
• Hospitals & Clinics
• Service Suppliers
• Potential Investors
• Key executive (CEO and COO) and strategy growth manager

Access Report @ https://www.wiseguyreports.com/reports/860844-global-hiv-vaccines-market-development-and-forecast-to-2027

Key Findings
• The global HIV vaccines market is expected to grow at a CAGR of 5.0% between 2017 and 2027, driven by growth from both developed and emerging markets
• North America contributed more than 44% of the total market size in 2017. Emerging markets such as China and India are expected to generate significant demand for HIV vaccines during the period, 2017-2027

As per the MRFR analysis, the global HIV vaccines market is expected to reach $2.7 billion by 2027. The market in Europe is estimated to be around $ 437 million in 2017 and is anticipated to reach $ 757 million by 2027. Asia-Pacific is expected to grow at a moderate pace during the forecast period.

The reports also cover country level analysis:
• Americas
o North America
§ US
§ Canada
o South America
• Europe
o Western Europe
o Germany
o France
o U.K.
o Italy
o Spain
o Rest of Western Europe
o Easter Europe
• Asia-Pacific
o China
o Japan
o India
o Australia
o Republic of Korea
o Rest of Asia-Pacific

…CONTINUED

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=860844

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Seborrhea Therapeutic and Drug Pipeline Review H1


.

.

Seborrhea Treatment Pipeline Review H1 2017

PUNE, INDIA, March 30, 2017 /EINPresswire.com/ — Seborrhea – Pipeline Review, H1 2017

Summary
Seborrhea is form of skin eczema that mainly affects scalp, ears, face, chest, and folds of skin. Symptoms include skin flakes, red skin, itching and skin lesions. Risk factors include stress or fatigue, skin acne and obesity. Treatment includes antifungal medications.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/1095886-seborrhea-pipeline-review-h1-2017

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Seborrhea – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Seborrhea (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Seborrhea (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Seborrhea and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase II, Preclinical and Discovery stages are 1, 2, 2 and 2 respectively.

Seborrhea (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Seborrhea (Dermatology).
– The pipeline guide reviews pipeline therapeutics for Seborrhea (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Seborrhea (Dermatology) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Seborrhea (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Seborrhea (Dermatology)

Reasons to buy
– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Find and recognize significant and varied types of therapeutics under development for Seborrhea (Dermatology).
– Classify potential new clients or partners in the target demographic.
– Develop tactical initiatives by understanding the focus areas of leading companies.
– Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
– Formulate corrective measures for pipeline projects by understanding Seborrhea (Dermatology) pipeline depth and focus of Indication therapeutics.
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Content: Key Points
List of Tables
List of Figures
Introduction
Seborrhea – Overview
Seborrhea – Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Seborrhea – Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Seborrhea – Companies Involved in Therapeutics Development
Aclaris Therapeutics Inc
Amorepacific Corp
Biomar Microbial Technologies
EpiPharm AG
Phosphagenics Ltd
Vyome Biosciences Pvt Ltd
Seborrhea – Drug Profiles
artemether – Drug Profile
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/1095886-seborrhea-pipeline-review-h1-2017

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire